Mammographic density as a risk factor for breast cancer in a German case-control study

European Journal of Cancer Prevention

Volumn 20, Issue 1, 2011, Pages 1-8

  Heusinger, Katharina ^a   Loehberg, Christian R ^a   Haeberle, Lothar ^a   Jud, Sebastian M ^a   Klingsiek, Peter ^a   Hein, Alexander ^a   Bayer, Christian M ^a   Rauh, Claudia ^a   Uder, Michael ^b   Cavallaro, Alexander ^b   May, Matthias S ^b   Adamietz, Boris ^b   Schulz Wendtland, Ruediger ^b   Wittenberg, Thomas ^c   Wagner, Florian ^c   Beckmann, Matthias W ^a   Fasching, Peter A ^d  

^a University Breast Center Franconia   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c FRAUNHOFER INSTITUTE FOR INTEGRATED CIRCUITS IIS   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CONTROLLED STUDY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHIC PERCENT DENSITY; MAMMOGRAPHY; NULLIPARA; ONCOLOGICAL PARAMETERS; PARITY; POSTMENOPAUSE; PRIMIGRAVIDA; PRIORITY JOURNAL; RISK FACTOR;

AGE FACTORS; AGED; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PARITY; RISK FACTORS;

EID: 78650513953     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328341e2ce     Document Type: Article

References (44)

1. Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, et al. (2010). Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 102:650-662.
2. Barlow WE,White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, et al. (2006). Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98:1204-1214.
3. Biong M, Gram IT, Brill I, Johansen F, Solvang HK, Alnaes GI, et al. (2010). Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC Med Genomics 3:9.
4. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. (1995). Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670-675.
5. Boyd NF, Lockwood GA, Martin LJ, Knight JA, Jong RA, Fishell E, et al. (1999). Mammographic densities and risk of breast cancer among subjects with a family history of this disease. J Natl Cancer Inst 91:1404-1408.
6. Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB (2000). Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study. Eur J Cancer Prev 9:15-24.
7. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005). Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808.
8. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, et al. (2006). Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15:2086-2092.
9. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. (2007). Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227-236.
10. Brisson J, Sadowsky NL, Twaddle JA, Morrison AS, Cole P, Merletti F (1982). The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol 115:438-443.
11. Brower V (2010a). Homing in on mechanisms linking breast density to breast cancer risk. J Natl Cancer Inst 102:843-845.
12. Brower V (2010b). Breast density gains acceptance as breast cancer risk factor. J Natl Cancer Inst 102:374-375.
13. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. (1995). Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Inst 87:1622-1629.
14. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M, et al. (2001). Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12:103-110.
15. Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Heiss G, et al. (2010). Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women's Health Initiative AACR Annual Meeting. Abstract 5741.
16. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, et al. (2006). Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 98:1215-1226.
17. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW (2004). Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621-628.
18. De Waard F, Rombach JJ, Collette HJ, Slotboom B (1984). Breast cancer risk associated with reproductive factors and breast parenchymal patterns. J Natl Cancer Inst 72:1277-1282.
19. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, et al. (2009). Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18:1131-1139.
20. Fasching PA, Von Minckwitz G, Fischer T, Kaufmann M, Schultz-Zehden B, Beck H, et al. (2007). The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs. Breast Cancer Res Treat 101:95-104.
21. Fasching PA, Loehberg CR, Strissel PL, Lux MP, Bani MR, Schrauder M, et al. (2008). Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients. Breast Cancer Res Treat 112:89-98.
22. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, et al. (2009). Five polymorphisms and breast cancer risk: Results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 18:1610-1616.
23. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003). Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30-37.
24. Harrel FE Jr, Lee LK, Mark DB (1996). Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387.
25. Harvey JA, Bovbjerg VE (2004). Quantitative assessment of mammographic breast density: Relationship with breast cancer risk. Radiology 230: 29-41.
26. Kotsuma Y, Tamaki Y, Nishimura T, Tsubai M, Ueda S, Shimazu K, et al. (2008). Quantitative assessment of mammographic density and breast cancer risk for Japanese women. Breast 17:27-35.
27. Lam PB, Vacek PM, Geller BM, Muss HB (2000). The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont. Cancer 89:369-375.
28. Li J, Eriksson L, Humphreys K, Czene K, Liu J, Tamimi RM, et al. (2010). Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer. Breast Cancer Res 12:R19.
29. Loehberg CR, Jud SM, Haeberle L, Heusinger K, Dilbat G, Hein A, et al. (2010). Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial. Breast Cancer Res Treat 121:101-110.
30. Martin LJ, Melnichouk O, Guo H, Chiarelli AM, Hislop TG, Yaffe MJ, et al. (2010). Family history, mammographic density, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 19:456-463.
31. McCormack VA, Dos Santos Silva I (2006). Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159-1169.
32. Milne RL, Benitez J, Nevanlinna H, Heikkinen T, Aittomaki K, Blomqvist C, et al. (2009). Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst 101:1012-1018.
33. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001). Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171-176.
34. Schrauder M, Frank S, Strissel PL, Lux MP, Bani MR, Rauh C, et al. (2008). Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. J Cancer Res Clin Oncol 134:873-882.
35. Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A,Wozniak E, et al. (2009). A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 41:996-1000.
36. Stone J, Warren RM, Pinney E, Warwick J, Cuzick J (2009). Determinants of percentage and area measures of mammographic density. Am J Epidemiol 170:1571-1578.
37. Tice JA, Cummings SR, Ziv E, Kerlikowske K (2005). Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94:115-122.
38. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, BarlowWE, Kerlikowske K (2008). Using clinical factors and mammographic breast density to estimate breast cancer risk: Development and validation of a new predictive model. Ann Intern Med 148:337-347.
39. Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, et al. (1998). The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 7:43-47.
40. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, et al. (2003). Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332-338.
41. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000). Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11:653-662.
42. Vachon CM, Van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS (2007a). Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9:217.
43. Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, et al. (2007b). Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 16:43-49.
44. Wolfe JN, Saftlas AF, Salane M (1987). Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: A case-control study. AJR Am J Roentgenol 148:1087-1092.